Last Updated: February, 2026
Trusted by 200+ Clients
Compare & Choose the Right Report Version for You
How to Order Your Report?
The report provides a detailed analysis essential for establishing a Selumetinib production plant. It encompasses all critical aspects necessary for Selumetinib production, including the cost of Selumetinib production, Selumetinib plant cost, Selumetinib production costs, and the overall Selumetinib production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Selumetinib production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Selumetinib is an FDA-approved oral inhibitor used for treating symptomatic, inoperable plexiform neurofibromas in pediatric patients aged 2+ with neurofibromatosis type 1. It reduces tumour volume, pain, disfigurement, and functional impairments like motor dysfunction through RAS and MAPK pathway blockade. It shows benefits in adult NF1 patients with similar tumours, improving quality of life and neurocognitive function. It is also utilised for radioiodine-refractory thyroid cancer (enhancing RAI uptake), biliary tract cancer, and solid tumours with mutations. It is used in combination with docetaxel, chemotherapy, or immunotherapy to extend progression-free survival. Its common side effects include vomiting, abdominal pain, diarrhoea, nausea, rash, dry skin, fatigue, pyrexia/fever, musculoskeletal pain, etc.
The market for Selumetinib is influenced by rising cases of neurofibromatosis type 1. Its FDA label expansions to adults and infants as young as one year contribute to its demand for targeted MEK inhibitors in orphan oncology. The strong clinical trial expansions into low-grade glioma, uveal melanoma, and KRAS-mutant cancers boost its demand further. Factors like high orphan drug pricing pressures and limited GMP-certified API suppliers affect industrial Selumetinib procurement.
The regulatory hurdles for pediatric and adult indications that require DMFs and CEPs, and supply chain constraints from single-source production impacts its sourcing. Also, hospital and speciality pharmacy dominance via tenders and support programs, and strategies like volume contracts and inventory buffers amid clinical trials affect its market dynamics.
According to the Selumetinib production plant project report, the key raw materials used in the production of Selumetinib include 2,3,4-Trifluorobenzoic Acid, Nitric Acid, Ammonia, and O-(2-Hydroxyethyl)Hydroxylamine.
The extensive Selumetinib production cost report consists of the following major industrial production process:
Selumetinib exists as the hydrosulfate salt form with a molecular formula of C17H15BrClFN4O3·H2SO4 with a molecular weight of 557.74 g/mol. It appears as a beige to off-white powder with a density of 1.69 g/cm³. Its melting point is not precisely reported, but stable under refrigerated storage (-20 degree Celsius). It shows high solubility in DMSO and moderate solubility in ethanol, but low aqueous solubility improved by salt form. It has a logP and XLogP3 value of around 3.6, indicating moderate lipophilicity. It has the topological polar surface area 88.4 Ų with 3 hydrogen bond donors, 6 acceptors, and 6 rotatable bonds.
Selumetinib Production Cost Report
Choose What's Right for You
Pay Via
| Particulars | Details |
|---|---|
| Product Name | Selumetinib |
| Scope | Production Process: Process Flow, Material Flow, Material Balance Raw Material and Product Specifications: Raw Material Consumption, Product and Co-product Generation Land and Site Cost: Offsites/Civil Works, Equipment Cost, Auxiliary Equipment Costs, Contingency, Engineering and Consulting Charges, Working Capital Variable Cost: Raw Material, Utilities, Other Variable Costs Fixed Cost: Labor Requirements and Wages, Overhead Expenses, Maintenance Charges, Other Fixed Costs Financing Costs: Interest on Working Capital, Interest on Loans Other Costs: Depreciation Charges, General Sales and Admin Cost |
| Currency | US$ (Data can also be provided in the local currency) |
| Pricing and Purchase Options | Basic: US$ 2499 Premium: US$ 3499 Enterprise: US$ 4799 |
| Customization Scope | The report can be customized as per the requirement of the customer |
| Post-Sale Analysts Report | 10-12 weeks of post-purchase analyst support after report delivery for any queries from the deliverable |
| Delivery Format | PDF and Excel format through email (editable version in PPT/Word format of the report can be also provided on special request) |
At Procurement Resource, we not only focus on optimizing the should cost of production for Selumetinib but also provide our clients with extensive intel and rigorous information on every aspect of the production process. By utilizing a comprehensive cost model, we help you break down expenses related to raw materials, labor, and technology, offering clear pathways to savings. We also assist in evaluating the capital expenditure (CAPEX) and operating expenses (OPEX), which are often measured as cost per unit of production, such as USD/MT, ensuring that your financial planning is aligned with industry benchmarks.
We offer valuable insights on the top technology providers, in-depth supplier database, and best manufacturers, helping you make informed decisions to improve efficiency. Additionally, we design the most feasible layout for your production needs, ensuring the entire process runs smoothly. By minimizing the cash cost of production, we ensure that you stay competitive while securing long-term profitability in the growing Selumetinib market. Partnering with Procurement Resource guarantees that every aspect of your production is cost-efficient, advanced, and tailored to your specific requirements.
Vishakha Agrawal
Lead - Social & Development Research
Delivering procurement intelligence and supply chain analytics across healthcare, FMCG, and chemicals sectors, with expertise in cost modeling, vendor mapping, and spend optimization to support data-driven sourcing decisions and procurement outcomes.
Need more help?
Still Need Help?
